In the increasingly worrying fight against antibiotic resistance, three scientific teams from public research in Grenoble and Marseille have just published an article in PNAS, the journal of the American Academy of Sciences, on an antimicrobial peptide that shows great promise as a new antibiotic: RumC1. Its major advantage? It is produced by a bacterium present in our gastrointestinal tract.